BMY News and Press, Bristol-Myers Squibb Company From 05/27/24

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

2024-05-26 08:00:00 ET Summary Buying quality companies at attractive valuations with post-inflation income may be a winning strategy. Bristol Myers Squibb stock is trading below its value 10 years ago, with a 6% yield and a promising pipeline. MPLX LP stock is also trading be...

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

2024-05-25 09:00:00 ET Summary We will lay out the basis for a retirement portfolio with a sustainable income and growth. The portfolio will aim to generate a 5% income while providing above-average growth to beat inflation and more. The portfolio will be structured into three...

2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...

2024-05-24 11:03:44 ET Summary The "Sell in May and go away" adage suggests selling stocks in May and returning in November, but historical data shows that June and July have been strong months. September is consistently the worst month for the stock market, with unpredictable ret...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2024 Hybrid Congress. Data from more than 130 com...

2024-05-23 12:36:52 ET Summary Lantheus Holdings, Inc. excels in radiopharmaceuticals, with PYLARIFY's dominance in PSMA PET imaging. The market for radiopharmaceuticals is expanding beyond all expectations by both industry experts and the company's management. Lantheus is act...

BALTIMORE, May 23, 2024 (GLOBE NEWSWIRE) -- Lawsuits have been filed alleging that a number of large corporate employers have offloaded billions of dollars in pension obligations to Athene Annuity and Life Company and/or Athene Annuity & Life Assurance Company of New York, subsidiaries of Ath...

2024-05-23 09:58:25 ET Summary Bristol Myers Squibb shares have plummeted due to concerns about patent expirations and growth prospects. BMY stock is currently trading near its 200-week moving average, which historically has been a good buying opportunity. The company has made...